However, GLP-1 medications and MHT may not be suitable for certain people, and not all GLP-1 medications are FDA approved for weight loss
Before you discontinue GLP-1 treatment, sharing your genetic predisposition data and current metabolic biomarkers with your provider can enable a more nuanced conversation about your individual weaning timeline, rebound risk mitigation, and whether alternative peptide therapies or ongoing support may be appropriate for your long-term health goals
Understanding Endoscopic Sleeve Gastroplasty (ESG): A Minimally Invasive Weight Loss Solution Benefits, Procedure, and Risks of Endoscopic Sleeve Gastroplasty (ESG) Procedure overview Preparation: Fasting and pre-operative assessment
Genetic Variation in the Histamine Production, Response, and Degradation Pathway Is Associated with Histamine Pharmacodynamic Response in Children with Asthma. Frontiers in Pharmacology, vol
There is insufficient evidence on which combination of hypoglycemic agents best improves health outcomes before escalating to insulin therapy